secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0000950170-24-102851
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Michael J. Fox resigns from Cue Biopharma board effective Aug 28, 2024
-------------------------------------------------------------------------------

- Michael J. Fox resigned as director and from all board committees on August 28, 2024.
- Resignation not related to any disagreement with the company on operations, policies, or practices.
- No replacement director has been announced or named in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000095017024102851/0000950170-24-102851-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000095017024102851/cue-20240828.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-102851

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer